دانلود رایگان مقاله انگلیسی عوامل موثر بر سلامت مرتبط با کیفیت زندگی در بیماران با نارسایی قلبی - هینداوی 2017

This study identified factors affecting health related quality of life (HRQOL) in 300 hospitalized patients with heart failure (HF). Data were collected by the completion of a questionnaire which included patients’ characteristics and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Analysis of data showed that the median of the total score of MLHFQ was 46 and the median of the physical and mental state was 22 and 6, respectively. Also, participants who were householders or had “other” professions had lower score of 17 points and therefore better quality of life compared to patients who were civil/private employees (?<0.001 and ?<0.001, resp.). Patients not receiving anxiolytics and antidepressants had lower quality of life scores of 6 and 15.5 points, respectively, compared to patients who received (?=0.003 and ?<0.001, resp.). Patients with no prior hospitalization had lower score of 7 points compared to those with prior hospitalization (?=0.002), whereas patients not retired due to the disease had higher score of 7 points (?=0.034). Similar results were observed for the physical and mental state. Improvement of HF patients’ quality of life should come to the forefront of clinical practice.

6. Conclusions

Measuring health related quality of life is increasingly important in both clinical practice and research and constitutes a challenge for clinicians involved in the care of HF. Given the high incidence of comorbidities in heart failure, it is essential to provide multidisciplinary care involving other specialties apart from cardiologists. Early assessment of factors affecting quality of life would have a positive effect on disease management and outcomes. The study findings underscore the importance of individualized care for HF patients and suggest future directions for research in this important area. Finally, clinicians should maintain focus on treating disease, maximizing life expectancy, and optimizing quality of life for HF patients at all disease stages.